Related Experiment Video

Updated: May 2, 2026

Practical Considerations in Studying Metastatic Lung Colonization in Osteosarcoma Using the Pulmonary Metastasis Assay
07:44

Practical Considerations in Studying Metastatic Lung Colonization in Osteosarcoma Using the Pulmonary Metastasis Assay

Published on: March 12, 2018

9.4K

MicroRNAs in osteosarcoma: from biological players to clinical contributors, a review

Guangxin Zhou1, Xin Shi, Junfeng Zhang

  • 1Department of Orthopaedics, Jinling Hospital, Nanjing, Jiangsu, China.

The Journal of International Medical Research
|April 10, 2013
PubMed

Insights

MicroRNAs (miRNAs) are key regulators in osteosarcoma, influencing cancer progression and treatment resistance. Understanding these small noncoding RNAs offers new diagnostic and therapeutic strategies for this bone cancer.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Osteosarcoma is a primary bone cancer primarily affecting children and adolescents, characterized by high morbidity.
  • The molecular mechanisms of metastasis and chemoresistance in osteosarcoma are not fully understood.
  • MicroRNAs (miRNAs) are small noncoding RNAs that regulate gene expression and are implicated in various pathophysiological processes, including cancer.

Purpose of the Study:

  • To review the current understanding of microRNA roles in osteosarcoma.
  • To explore the potential of miRNAs as diagnostic and prognostic biomarkers.
  • To discuss the therapeutic implications of targeting miRNAs in osteosarcoma management.

Main Methods:

  • Literature review of studies investigating microRNAs in osteosarcoma.
  • Analysis of research on miRNA involvement in osteosarcoma initiation, progression, metastasis, and chemoresistance.
  • Synthesis of findings on miRNA-based diagnostic, prognostic, and therapeutic strategies.

Main Results:

  • MicroRNAs play critical roles in regulating gene networks involved in osteosarcoma development and progression.
  • Specific miRNAs are associated with metastasis formation and the development of chemoresistance in osteosarcoma.
  • miRNA expression profiles show potential for early diagnosis and prognosis prediction.
  • Targeting miRNAs presents a promising therapeutic avenue for osteosarcoma.

Conclusions:

  • MicroRNAs are crucial regulators in osteosarcoma, impacting its initiation, progression, and response to therapy.
  • Further research into miRNAs can lead to novel diagnostic tools and targeted treatment strategies for osteosarcoma.
  • The field of miRNA research is rapidly advancing and poised to revolutionize osteosarcoma management.

More Related Videos

Three-Dimensional Bone Extracellular Matrix Model for Osteosarcoma08:07

Three-Dimensional Bone Extracellular Matrix Model for Osteosarcoma

Published on: April 12, 2019

6.7K
Intratibial Osteosarcoma Cell Injection to Generate Orthotopic Osteosarcoma and Lung Metastasis Mouse Models04:25

Intratibial Osteosarcoma Cell Injection to Generate Orthotopic Osteosarcoma and Lung Metastasis Mouse Models

Published on: October 28, 2021

10.1K

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
21.1K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.0K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.6K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.0K